Table 1 Relationship between DACH1 expression and clinicopathological characteristics in 120 LSCC patients
From: Effect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma
| Clinicopathological characteristics | DACH1 | expression | p-value |
|---|---|---|---|
| <mean value% | ≥mean value% | ||
| N = 120 | 60 (50.0%) | 60 (50.0%) | |
| Age (mean ± SD; years) | 0.239 | ||
| < 61 ± 8.11 | 38 (31.7%) | 44 (36.7%) | |
| ≥ 61 ± 8.11 | 22 (18.3%) | 16 (13.3%) | |
| Gender | 0.194 | ||
| Male | 32 (26.7%) | 39 (32.5%) | |
| Female | 28 (23.3%) | 21 (17.5%) | |
| T classification | 0.002 | ||
| T1-T2 | 49 (40.8%) | 33 (27.5%) | |
| T3-T4 | 11 (9.2%) | 27 (22.5%) | |
| Lymph node metastases | 0.010 | ||
| Yes | 40 (33.3%) | 52 (43.3%) | |
| No | 20 (16.7%) | 8 (6.7%) | |
| Primary location | 0.006 | ||
| Supraglottic | 41 (34.2%) | 26 (21.7%) | |
| Glottic | 19 (15.8%) | 34 (28.3%) | |
| Differentiation | 0.099 | ||
| G1 | 23 (19.2%) | 32 (26.7%) | |
| G2-G3 | 37 (30.8%) | 28 (23.3%) | |
| Clinical stage | 0.016 | ||
| I-II | 29 (24.2%) | 42 (35.0%) | |
| III-IV | 31 (2ss5.8%) | 18 (15.0%) | |
| Smoking | 0.002 | ||
| Never | 4 (3.3%) | 17 (14.2%) | |
| Ever | 56 (46.7%) | 43 (35.8%) | |
| Drinking | 0.039 | ||
| Never | 11 (9.2%) | 21 (17.5%) | |
| Ever | 49 (40.8%) | 39 (32.5%) |